Gene Symbol | CHRNA7 |
---|---|
Entrez Id | 1139 |
Position | chr15:32322691..32462384 |
Description | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
Gene type | protein-coding |
SNP | Position | Alelle | Gene | Annotation | Info | Or | Se | P-value | eQTL | Score* |
---|---|---|---|---|---|---|---|---|---|---|
rs1039394 | 15:32407729 | C/G | CHRNA7 | intron | 0.681 | 0.94393 | 0.0258 | 0.0253 | ![]() | 7 |
rs10438287 | 15:32402003 | A/G | CHRNA7 | intron | 0.989 | 1.00975 | 0.0131 | 0.4571 | ![]() | 7 |
rs10438339 | 15:32400218 | T/C | CHRNA7 | intron | 0.802 | 1.00985 | 0.0118 | 0.4059 | ![]() | 5 |
rs10438340 | 15:32401406 | T/C | CHRNA7 | intron | 0.975 | 0.98985 | 0.0132 | 0.4404 | ![]() | 7 |
rs10438341 | 15:32401608 | T/C | CHRNA7 | intron | 0.981 | 1.01319 | 0.0114 | 0.2492 | ![]() | 5 |
rs10438342 | 15:32402046 | A/G | CHRNA7 | intron | 0.993 | 0.98669 | 0.0113 | 0.2378 | ![]() | 5 |
rs10459632 | 15:32428968 | C/G | CHRNA7 | intron | 0.923 | 0.97726 | 0.0110 | 0.03653 | ![]() | 6 |
rs10459633 | 15:32429000 | A/G | CHRNA7 | intron | 0.744 | 0.98511 | 0.0126 | 0.2361 | ![]() | 6 |
rs10468022 | 15:32423933 | A/G | CHRNA7 | intron | 0.981 | 0.98246 | 0.0107 | 0.09736 | ![]() | 6 |
rs10775173 | 15:32343377 | T/C | CHRNA7 | intron | 0.725 | 1.00341 | 0.0161 | 0.834 | ![]() | 5 |
SNP | Position | Alelle | Gene | Annotation | Info | Or | Se | P-value | eQTL | Score* |
score | supporting data | score | supporting data |
---|---|---|---|
1a | eQTL + TF binding + matched TF motif + matched DNase Footprint + DNase peak | 6 | other |
2a | TF binding + matched TF motif + matched DNase Footprint + DNase peak | 5 | TF binding or DNase peak |
1b | eQTL + TF binding + any motif + DNase Footprint + DNase peak | 4 | TF binding + DNase peak |
2b | TF binding + any motif + DNase Footprint + DNase peak | 3b | TF binding + matched TF motif |
1c | eQTL + TF binding + matched TF motif + DNase peak | 1f | eQTL + TF binding / DNase peak |
2c | TF binding + matched TF motif + DNase peak | 3a | TF binding + any motif + DNase peak |
1d | eQTL + TF binding + any motif + DNase peak | 1e | eQTL + TF binding + matched TF motif |
Reference | Study type | Sample size |
---|---|---|
18668039 | GWAS | Phase I: 1433 cases and 33250 controls; Phase II: 3285 cases and 7960 controls |
18668038 | GWAS | 3391 cases; 3181 controls |
19880096 | GWAS | 575 cases; 564 controls |
21489405 | GWAS | 834 cases; 672 controls |
19181681 | GWAS | 471 cases; 2792 controls |
22118685 | GWAS | 235 cases; 191 controls |
Reference | Study type | Sample size |